PMID: 11904609Mar 21, 2002Paper

The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination

American Journal of Obstetrics and Gynecology
Jan E Dickinson, Sharon F Evans

Abstract

The purpose of this study was to compare the clinical efficacy and side effects of 3 doses of intravaginal misoprostol for second-trimester pregnancy termination. This was a prospective randomized, double-blind controlled clinical trial of 150 women who underwent pregnancy termination between 14 and 30 weeks of gestation. Three intravaginal misoprostol regimens were compared: 200 microg misoprostol at 6-hour intervals (group 1), 400 microg misoprostol at 6-hour intervals (group 2), and a loading dose of 600 microg misoprostol followed by 200 microg at 6-hour intervals (group 3). There was a significant difference in the median time to achieve delivery among the 3 groups: group 1 (18.2 hours [IQ, 13.3-32.5 hours]) vs group 2 (15.1 hours [IQ, 10.9-23.7 hours]) vs group 3 (13.2 hours [IQ, 11.2-21.7 hours]; P =.035). Fifty-nine percent of the women in group 1, 76% of the women in group 2, and 80% of the women in group 3 delivered within 24 hours (P =.013). There were 7.8% of the women in group 1, 0% of the women in group 2, and 2% of the women in group 3 who were undelivered at 48 hours (P =.02). There was an increase in the incidence of fever in the first 12 hours (P =.038) and in the incidence of vomiting within 3 hours of the in...Continue Reading

Citations

Sep 17, 2008·Human Reproduction·Helena von HertzenUNKNOWN WHO Research Group on Post-ovulatory Methods of Fertility Regulation
Dec 5, 2009·Obstetrics and Gynecology International·Kristin Van MenselMyriam Hanssens
Sep 27, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·M I Nor AzlinM A Jamil
Jan 13, 2010·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Bulent YilmazNuri Danisman
Oct 28, 2011·Taiwanese Journal of Obstetrics & Gynecology·Chen-Ju LinChih-Ping Chen
Apr 22, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Dana VitnerLior Lowenstein
Aug 14, 2010·Contraception·Joseph Franciscus Gertrudis Maria BrounsWillem Jacobus van Wijngaarden
Mar 30, 2010·Best Practice & Research. Clinical Obstetrics & Gynaecology·Vivian C Y LeeP C Ho
May 12, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Norbert WinerPatrick Rozenberg
Jul 15, 2005·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·C Capilla Montes, T Bermejo Vicedo
Oct 27, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P C HoO S Tang
Jul 30, 2004·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jan E Dickinson
Feb 26, 2005·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jodie DoddJudy Coffey
Aug 17, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Yongyoth HerabutyaPiyaporn Punyavachira
Sep 26, 2009·BJOG : an International Journal of Obstetrics and Gynaecology·A Elati, A D Weeks
Nov 23, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Sally B RoseAnn Simmons
Apr 7, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Yasmina CabreraJulio Alvarez
Feb 26, 2011·The Journal of Obstetrics and Gynaecology Research·Talat Umut Kutlu DilekSaffet Dilek
Aug 6, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Roel De HeusBen W J Mol
Feb 14, 2006·Contraception·Chafika MazouniFlorence Bretelle
Jul 5, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·E TarimF Yanik
Jan 11, 2014·Contraception·Hillary BrackenUNKNOWN Buccal misoprostol for IUFD Research Group
Feb 11, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Alice G MarkLynn Borgatta
Aug 6, 2015·Journal of Obstetrics and Gynaecology of India·Deepika NautiyalNavnita Banerjee
Mar 26, 2009·American Journal of Obstetrics and Gynecology·Cassing Hammond
Jul 28, 2009·American Journal of Obstetrics and Gynecology·Jan E Dickinson, Dorota A Doherty
Mar 26, 2004·American Journal of Obstetrics and Gynecology·Hani A AkouryRory Windrim
Aug 16, 2005·American Journal of Obstetrics and Gynecology·Rodney K Edwards, Shireen M Sims
Jun 15, 2011·Contraception·Lynn BorgattaUNKNOWN Society of Family Planning
Jan 5, 2011·Taiwanese Journal of Obstetrics & Gynecology·Shi-Yann ChengShu-Chen Pei
Mar 12, 2003·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A A Rouzi
Nov 13, 2002·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·I MendilciogluB Trak
Mar 13, 2014·Clinical Obstetrics and Gynecology·Laura Goetzl
Jul 21, 2006·The Cochrane Database of Systematic Reviews·J P NeilsonJ Vazquez
Apr 23, 2017·The Journal of Family Planning and Reproductive Health Care·Daniel Seow Choon KohKok Hian Tan
Aug 2, 2005·Obstetrics and Gynecology·Alisa B GoldbergPhilip D Darney
Dec 7, 2007·Obstetrics and Gynecology·Nathalie KappNilda Moreno
Jun 18, 2019·The Cochrane Database of Systematic Reviews·Marike LemmersJames P Neilson
Sep 8, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Amanda CleeveAntonella Lavelanet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.